Search research articles
Contact Us
Filters
Showing results (151-160 of 180) with videos related to
Page
of 18
Sort By:
Transplantation and Cellular Therapy
|
September 19, 2021
Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell Transplantation
Nicholas A Szewczyk, An Ngo-Huang, Tacara N Soones, et al.
Blood Advances
|
December 11, 2019
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation
Li Li, Han Chen, David Marin, et al.
Transplantation and Cellular Therapy
|
July 30, 2021
Myeloablative Fractionated Busulfan With Fludarabine in Older Patients: Long Term Disease-Specific Outcomes of a Prospective Phase II Clinical Trial
Rohtesh S Mehta, Roland Bassett, Julianne Chen, et al.
Science Advances
|
July 26, 2023
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering
Li Li, Vakul Mohanty, Jinzhuang Dou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 5, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells
Amanda Olson, Ye Li, David Marin, et al.
Blood Advances
|
April 3, 2020
Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity
Ankur Varma, Susan C Abraham, Rohtesh S Mehta, et al.
Blood
|
June 2, 2016
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation
Takuya Sekine, David Marin, Kai Cao, et al.
Blood Advances
|
August 23, 2023
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities
Uday R Popat, Oren Pasvolsky, Roland Bassett, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2020
Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy
Rafet Basar, Nadima Uprety, Emily Ensley, et al.
Cancer
|
July 13, 2016
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation
Sameh Gaballa, Isabell Ge, Riad El Fakih, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 180) with videos related to
Sort By:
Page
of 18
Transplantation and Cellular Therapy
|
September 19, 2021
Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell Transplantation
Nicholas A Szewczyk, An Ngo-Huang, Tacara N Soones, et al.
Blood Advances
|
December 11, 2019
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation
Li Li, Han Chen, David Marin, et al.
Transplantation and Cellular Therapy
|
July 30, 2021
Myeloablative Fractionated Busulfan With Fludarabine in Older Patients: Long Term Disease-Specific Outcomes of a Prospective Phase II Clinical Trial
Rohtesh S Mehta, Roland Bassett, Julianne Chen, et al.
Science Advances
|
July 26, 2023
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering
Li Li, Vakul Mohanty, Jinzhuang Dou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 5, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells
Amanda Olson, Ye Li, David Marin, et al.
Blood Advances
|
April 3, 2020
Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity
Ankur Varma, Susan C Abraham, Rohtesh S Mehta, et al.
Blood
|
June 2, 2016
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation
Takuya Sekine, David Marin, Kai Cao, et al.
Blood Advances
|
August 23, 2023
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities
Uday R Popat, Oren Pasvolsky, Roland Bassett, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2020
Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy
Rafet Basar, Nadima Uprety, Emily Ensley, et al.
Cancer
|
July 13, 2016
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation
Sameh Gaballa, Isabell Ge, Riad El Fakih, et al.
Page
of 18